Join us Thursday 4/24 at 2pm Central Time, as we focus on the valuation range for Ford (F). Register here. HIDE

GTx (GTXI)

Add to Watchlists
Create an Alert
1.41 -0.01  -0.70% NASDAQ Apr 23, 4:59PM BATS Real time Currency in USD
View Full Chart
GTXI Price Chart
View All Events

GTXI Events

Date Type Description
Mar 04 Misc GTx, Inc. Q4 2013 Earnings Conference Call
Mar 04 Earnings GTx, Inc. Q4 2013 Earnings Results. Estimate: -0.13.
Nov 12 Misc GTx, Inc. To Host Third Quarter 2013 Financial Results Conference Call and Webcast
Nov 12 Earnings GTx, Inc Q3 2013 Release. Estimate: -0.21.
Jul 19 Earnings Gtx Provides Corporate Update and Second Quarter 2013 Financial Results. Estimate: -0.22.
May 03 Misc GTx, Inc. To Host First Quarter 2013 Financial Results Conference Call and Webcast
May 03 Earnings GTx, Inc. To Host First Quarter 2013 Financial Results. Estimate: -0.20.
View All Performance Charts

GTXI Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). GTx is down 71.46% over the last year vs S&P 500 Total Return up 22.59%, Actelion up 71.93%, and Gilead Sciences up 36.65%.

Get Quote for
Advertisement

Portfolio Strategies Featuring GTXI

Did GTx make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

GTXI Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Headquarters Country: United States
  • Headquarters State/Province: Tennessee
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: N/A
  • Last Fiscal Year End: N/A
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Industry Code: 3254
  • NAICS Sector: Manufacturing
  • NAICS Sector Code: 32

GTx, Inc. is biopharmaceutical company dedicated to the discovery, development and commercialization of small molecules that selectively target hormone pathways to treat cancer, osteoporosis and bone loss, muscle loss and other serious medical condition.

Recent Quotes

Symbol Price Chg Chg % Market Cap
GTXI 1.41 -0.01 -0.70% 89.09M
Create Watchlist from Quotes
Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.